COVID-19 mRNA Clinical Trials – A Comprehensive Guide
New Peer-Reviewed Study Exposes Everything in 1 Paper!
If you can’t pay for subscription, leave me a tip!
A hot of the press peer-reviewed paper was just published in Cureus and hasn’t gotten as much attention, even in the COVID-19 wise, medical freedom arenas, as I expected it would. Maybe it’s because everything in the paper is already known, it simply puts it all in one place in a nice, neat review article.
That being said, it is now one of the most downloaded and reviewed Cureus articles and has been rated with a high scholarly impact quotient by readers. And no surprise, the powers that be are putting pressure on Cureus to retract the paper.
It’s a bit long, but it’s a very good read and may even remind you of some concerns about the mRNA vaccine and trials that you had forgotten about…we can never forget!
It’s also a good paper to send to our normie friends/family and those who can’t fully grasp the extent to which the world has been fooled.
For those who don’t want to read the full paper it revisits the history of the mRNA vaccines and the clinical trials as well as safety and efficacy (including hospitalizations and deaths) thru 2023. Here are some of the main points.
mRNA and COVID-19 mRNA Vaccine History
10-15 years of vaccine testing is standard prior to approval. The mRNA vaccines completed the process in 7 months!
Prior to the COVID-19 mRNA vaccine the shortest period of vaccine testing prior to market release was 4 years.
Safety was not tested within normal scientific standards and toxicology testing was done.
Multiple vaccines have been prematurely released to market only to find there were devastating adverse reactions (AEs) include permanent injury and death.
1955 contaminated polio vaccine
1976 swine flu vaccine (Guillain-Barre & Death)
2009 connection with a specific flu vaccine and narcolepsy
Prior to the pandemic the USA government [NIH, Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defence (DOD)] had already invested $336 million in mRNA technology.
~ $31.5 billion was invested by the USA government alone into COVID-19 mRNA vaccines once the pandemic began. This included funds for development, testing and purchase.
Pre-pandemic and pre-purchase money spent suggests government bias to successful trial outcome and approval.
Such levels of spending continued throughout the pandemic. Ex. BARDA spent $40 billion in 2021 alone.
Remember this is all taxpayer money! And for a product that certainly caused more harm than good (as we will see below).
Based on all previous evidence of mRNA technology, it falls under the gene therapy product (GTP) category.
These GTP products were reclassified as “vaccines” allowing them to forgo proper safety testing.
Registrational Clinical Trials
Both Pfizer’s and Modera’s trials did not have sufficient statistical power to determine effectiveness against severe disease and death.
The participants were younger, healthier people not at risk of severe disease.
Pfizer’s trial had 1 severe COVID-19 case and Moderna had 0.
Pfizer and Moderna unblinded their trial at the 2- and 3-month mark respectably. Meaning the placebo group was offered the vaccine because it would not be ethical to keep a placebo control group since the vaccine was so “effective”. Therefore there was no longer control group data after the 5 month mark so there is no information on ongoing effectiveness or, more importantly, side effects.
This is a trick pharma companies use in their clinical trials to make drugs appear safe and effective.
Pfizer efficacy results were based on using “confirmed” cases only, meaning there had to be a positive PCR test. It did NOT include “suspected” cases where there was confirmed COVID-19 symptoms but not a positive PCR test.
If both confirmed and suspected cases are included in the efficacy calculation, the outcome is that it was only 29% effective, well below the FDA approval cut-off mark of 50%.
There was no reduction in all-cause mortality (ACM), this means death from any cause, not just COVID-19.
However, if the vaccines were reducing death from COVID-19 we would expect to see a reduction in ACM since COVID-19 would be removed as a contributor.
A possible explanation for equivalent ACM between the vaccine and placebo groups is that the vaccine was reducing COVID-19 deaths while increasing deaths from other causes at the same time, balancing the ACM numbers.
At the 6-month mark (including 4 months where the placebo group was allowed to get vaccinated), there was an additional 5 deaths, 2 of which occurred in placebo participants that chose to get vaccinated.
When including these new deaths, there was 20 in the vaccine group and 14 in the placebo group. This equals a 43% increase in ACM in the vaccinated.
There was a 45% increase in cardiovascular deaths for the vaccine groups in the Pfizer and Moderna trials.
The high effectiveness reports of 95% were relative risk reduction only.
ex. 1 case in the vax group and 20 cases in the unvaccinated group = 95% less cases in the vaccinated group. This can overestimate the vaccine benefits.
The absolute risk means calculating what your overall chances of getting COVID-19 would be without getting vaccinated and then comparing that to the overall chances of getting COVID-19 after getting vaccinated, not just comparing the number of cases in each group. Using the trial data, the absolute risk reduction for the Pfizer and Moderna vaccines were 0.7% and 1.1%. This means that at best the trials showed that getting vaccinated decreased your risk of getting COVID-19 by only about 1%. And that would be at the height of their effectiveness (not against new variants or wanning efficacy).
Using absolute risk reduction numbers, the number of people needed to vaccinate to prevent 1 mild-moderate COVID-19 case is between 88 and 142. When taking into consideration the infection fatality rate of SARS-CoV-2 the number of people needed to vaccinate to save 1 COVID-19 death was ~52,000.
Deaths from the vaccines are calculated to be 27 per 100,000 doses, meaning it likely killed 27 people to save 2 COVID-19 deaths.
COVID-19 mRNA Vaccine Harms
The trials used multiple tactics to reduce the tracking and reporting of AEs.
Such tactics align with previous findings that only ~5% of adverse events are reported in pharmaceutical company sponsored drug trials.
The trial data was not available to the public for independent scrutiny until the FDA was legally forced to release it after requesting a 75-year period to release to data. Data was not released until well into the vaccination campaign.
Deaths continued to occur after the 6-month reporting period and although the number of deaths was small, the death rate continued to increase for the vaccinated group past 6 months.
Trial data showed a 3.7 fold increase in cardiac related deaths.
There were only 38 overall deaths in 44,060 participants in the Pfizer’s trial. Based on expected population death rates, there should have been closer to 222 deaths.
This could have been attributed to patients who stopped following up. There we 395 “lost to follow up” participants…why did they stop following up? Did they die or get injured severely enough to prevent follow-up. Why didn’t Pfizer seek out explanation?
There was 1 serious adverse event (SAE) for every 800 people vaccinated.
Given the trial participants were younger, healthier individuals, this SAE rate would be expected to be higher in elderly, frail and sick people.
Trials showed a 2-4 fold higher risk of AE of special interest compared to the risk of COVID-19 hospitalization.
The official AE rate for other approved vaccines is 1/million, the trial showed a 600x higher risk, 1,250/million.
A whistle-blower reported multiple concerns with the trials including lack of timely AEs reporting follow-up, suggesting under reporting of AEs.
Pregnant women were specifically NOT included in the trials, yet the vaccine was approved for pregnant women!
The vaccines have been shown to cause innate immune system suppression, increasing the risk of infections and autoimmune diseases.
Vaccine caused 5-8x increase in stroke risk.
Poor Quality Control
The clinical trial vaccines and the vaccines rolled out to the public were made using 2 different methods. They were called process 1 and process 2.
Due to poor manufacturing quality control (suspected) in process 2:
Certain batches of the vaccine were contaminated with double stranded RNA and DNA orders of magnitude above industry accepted standards.
The presence of carcinogenic virus SV40 promoter.
No studies have been done to determine if DNA integration happens in cells of the vaccinated.
No comparison has been done between the vaccines from process 1 and process 2.
Effectiveness
Trials didn’t measure effectiveness against infection, only symptomatic cases, even though protection against infection is standard measure of vaccine effectiveness.
We know it they don’t prevent infection.
Trials didn’t measure effectiveness against transmission.
We know they don’t prevent transmission.
More recent data show that being up to date with vaccine booster causes a higher risk of COVID-19.
Recent evidence show there is NO reduction in severe disease or death from being vaccinated.
The paper also has a section explaining possible reasons the vaccines cause so many AEs as well as a section explaining why effectiveness is so poor. They are well written, and I suggest everyone read it.
The researchers conclude that the most concerning thing about the emergency use authorization was that the clinical trial clearly showed a significant risk of SAEs and death in an otherwise healthy population.
Using real world data years after vaccine rollout, research has continued to show vaccine ineffectiveness and increases in all-cause mortality across many countries. High end estimates of death from COVID-19 vaccines is 17 million excess deaths world-wide, suggesting an injection fatality rate of 0.1%. Remember SAE happen at a much higher rate than death and SAE are estimated at 1 in 800 doses. Also remember that some of the SAE may not cause immediate death but certainly can reduce lifespan.
One final last nugget from the paper was describing the evidence that long COVID-19 can be caused by the vaccine and the unvaccinated appear to be at the lowest risk of what is called long COVID-19, indicating that a large portion of what is being diagnosed as long COVID-19 may actually be long COVID-19 vaccine!